Search
Filter Results
Displaying 31–40 of 998 results
-
Sep 26, 2024
Vision: A Memoir of Blindness and Justice — A New York Times Editor’s Pick
“Tatel’s humility and tenacity shine. The result is a stirring reflection on an extraordinary life,” Publishers Weekly
-
Sep 26, 2024
Social media campaign to encourage personal story sharing to spread awareness about blinding diseases and empower involvement with the Foundation Fighting Blindness.
-
Sep 23, 2024
4DMT Planning Phase 3 Clinical Trial for Wet AMD Gene Therapy
Known as 4D-150, the wet AMD gene therapy performed well in a Phase 2b clinical trial.
-
Expert panelists will highlight the barriers that block blind and visually impaired people from engaging with your business and discuss how partnering with organizations like the Foundation Fighting Blindness can provide practical solutions to enhance your bottom line.
-
Sep 20, 2024
Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner
Dr. Zuhal Butuner talks about her company’s two emerging RNA therapies for LCA10 and USH2A.
-
Sep 18, 2024
AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical Trial
The trial is the first ever for a dual AAV gene therapy delivered to the retina.
-
Sep 18, 2024
Innovative Ways to Support Research for Treatments and Cures for Blinding Diseases
-
Sep 17, 2024
The Phase 3 trial is expected to begin in Q1 2025
-
Sep 16, 2024
Foundation Fighting Blindness Hosts Chicago Night for Sight Event
The October 5th event will raise awareness and fund research driving treatments and cures for blinding diseases and macular degeneration.
-
Sep 11, 2024
Recording Available: Foundation Insights Forum – August 29, 2024
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on August 29, 2024.